Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

ACXPACXP
3 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in ACURX PHARMACEUTICALS INC

Yes. Jane Street Group holds 15,727 shares of ACXP (Acurx Pharmaceuticals), worth $24,377, as of its Q2 2026 13F filing. It reduced the position by 38,915 shares (-71.2%) from Q1 2026. Jane Street Group has held ACXP since Q4 2025, across 3 quarterly 13F filings.

Current Value

$24,377

Current Shares

15,727

Total Value Change

-$2,373

Total Shares Change

+4,984

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
15,727
-71.2%
$24,3770.0%$1.55
0
2026-Q1
Increased
54,642
+408.6%
$202,7220.0%$1.48
25
2025-Q4
New
10,743
-
$26,7500.0%$2.62
30

Other major holders of ACXP: VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used